Sinomax Group Limited Overview
Sinomax is a Hong Kong-headquartered, Cayman-incorporated, family-controlled manufacturer of polyurethane foam and visco-elastic ("memory foam") sleep products — pillows, mattress toppers and mattresses — with a vertically integrated chain running from foam pouring in China and Vietnam to finished-goods plants in the PRC, Vietnam and the United States. It earns roughly 71% of revenue from health and household products sold to North American and European retailers, private-label programmes and e-commerce, and through its own SINOMAX retail counters in Hong Kong and the PRC; the remaining ~29% comes from bulk polyurethane foam (Tung Ah brand) sold to Chinese furniture makers. Revenue reached a record HK$4.70bn in FY2025 and grew a further 36% in 1H2026 after the Group took control of Danish trading house M DK Holdings and bought the VIBE mattress brand outright. The equity story is a growth-versus-margin tension: scale and geographic diversification are rising quickly, but net margins are sub-2%, leverage is up, and the shares trade at roughly 0.2x book.
The company's own description
In its FY2025 annual results announcement, the Group describes itself simply: it "manufactures and sells health and household products", with the Company acting as an investment holding company. The 2026 interim results expand on this: the Group sells health and household products — "quality visco-elastic pillows, mattress toppers and mattresses" — to wholesalers and retailers and directly to customers through self-operated stand-alone retail shops, concession counters in department stores and online platforms; it also sells polyurethane foam to furniture manufacturers. Operating segments are defined geographically (China market; North American market; Europe and other overseas markets).
Historically (pre-2020 segmentation, as summarised by 10jqka from company disclosures) the Group reported three business lines: (i) Export sales — wholesale of products to overseas customers; (ii) Retail and corporate sales — sales under the SINOMAX brand via own network, third-party distributors, corporate customers and e-commerce; and (iii) Polyurethane foam sales — wholesale of foam under the Tung Ah (東亞) brand to PRC furniture manufacturers. Those three economic engines still exist inside today's geographic segments.
Independent characterisation
Sinomax is best understood as a mid-tier, vertically integrated foam-to-finished-goods OEM/ODM with three distinct revenue engines:
-
North American OEM/private-label and e-commerce sleep products (FY2025: HK$1,773.6M, 37.8% of revenue). Sinomax USA manufactures mattresses (notably compressed "mattress-in-a-box"), toppers and pillows for large US bedding brands and retailers (historically including Serta Simmons Bedding, per the 2017 Annual Report) and for online channels, and since 2023 has marketed the VIBE brand (licensed from November 2022, owned outright from July 2025).
-
China market (FY2025: HK$1,857.7M, 39.6%), which combines (a) a commodity-like B2B business selling polyurethane foam to Chinese furniture manufacturers — HK$1,369.9M of Group revenue in FY2025 is foam, almost all of it booked in this segment — and (b) a branded consumer business (SINOMAX retail shops, department-store concession counters and e-commerce in Hong Kong, Macau and the PRC).
-
Europe and other overseas (FY2025: HK$1,065.4M, 22.7%), transformed in 2024–2025 by the M DK Holdings investment, which added a Danish sourcing/trading/design house selling sleep products, furniture and home accessories in Denmark, the EU and the US.
Revenue model
| Revenue mix by product type (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Health and household products (HK$M) | 2,370.0 | 1,980.3 | 2,365.4 | 2,728.9 | 3,326.7 |
| Polyurethane foam (HK$M) | 1,889.9 | 1,171.7 | 1,243.5 | 1,362.2 | 1,369.9 |
| Total revenue (HK$M) | 4,259.9 | 3,152.0 | 3,608.9 | 4,091.1 | 4,696.7 |
| Health & household share of revenue (%) | 55.6 | 62.8 | 65.5 | 66.7 | 70.8 |
Revenue is almost entirely product revenue recognised at a point in time (FY2025 notes: 100% of revenue from sale of goods). There is no material subscription, service or licensing income. Rental income (HK$9.6M in FY2025) and government subsidies (HK$7.9M) are reported as other income. The Group pays rather than receives royalties: accrued royalties were HK$18.8M at end-FY2025, consistent with licensed brands (e.g., the VIBE licence carried a minimum quarterly royalty of US$200,000 before the July 2025 buy-out).
Source: FY2022, FY2024, FY2025 annual results announcements, note 3.
Value-chain position and channels
Sinomax sits in the midstream: it buys chemical feedstocks (polyols, isocyanates/TDI-MDI and additives — inferred from the polyurethane process; specific supplier names are NPD), pours slabstock and visco-elastic foam in China and Vietnam, and converts foam into finished sleep products in China, Vietnam and the US. Channels are: (i) wholesale to brand owners and retailers (credit terms 7–90 days); (ii) department-store concession counters (department stores collect cash and remit net of commission on 30–120-day terms; concession commission HK$32.1M in FY2025); (iii) self-operated stand-alone shops; (iv) online platforms; and (v) foam sales to furniture manufacturers in the PRC.
Customer types and end-markets
Customers are (a) North American and European bedding brands, mass merchants and online retailers; (b) Chinese furniture manufacturers (foam); and (c) consumers in Hong Kong, Macau and the PRC. A single customer ("Customer A") contributed over 10% of revenue in FY2021 (HK$504.5M) and FY2022 (HK$329.7M); the identity is not disclosed, and no >10% customer was disclosed in the FY2024 or FY2025 announcements reviewed. End-markets are residential bedding (mattresses, toppers, pillows), upholstered furniture (via foam), and adjacent home-comfort products.
Strategy
Stated strategy — themes from the FY2025 Annual Results and 2026 Interim Results
Management's stated themes (paraphrased from the "Prospects" sections):
-
Overseas expansion, especially Europe and the US — continue advancing ongoing projects in these regions and increase market share (FY2025 Prospects).
-
Leverage the enlarged M DK platform — use MDKH's business platform and resources to deepen penetration in the US and Europe, strengthen sales and marketing, broaden the customer base and deepen existing relationships (1H2026 Prospects).
-
Mattress-in-a-box growth — expects sales of mattress-in-a-box to keep growing and contribute more sales and profit (FY2022, FY2024, FY2025 Prospects).
-
Streamline and cut costs — operational streamlining, resource allocation and synergies; cost-control in production and logistics (FY2024–1H2026).
-
Multi-country production network as a tariff hedge — factories in the PRC, US and Vietnam allow flexible deployment of capacity amid trade wars, tariffs and anti-dumping duties (FY2024 Prospects; FY2025 profit warning).
-
Brand ownership — move from licensee to owner (VIBE) to gain flexibility in positioning, marketing and expansion, including outside the licensed territories.
-
Tone: the Board describes itself as "cautiously optimistic".
Strategic initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Date | Initiative | Detail | Status |
|---|---|---|---|
| 14 Oct 2024 | Europe entry via M DK Holdings (45%) | EUR6.0M subscription | Completed; equity-accounted in FY2024 (share of profit HK$5.0M) |
| Oct–Dec 2024 | Dongguan capacity | Supplemental premises lease Oct 2024; 2025 Dongguan Lease (10 Dec 2024) | Completed |
| 7 Jul 2025 | VIBE brand IP buy-out | US$4.6M; replaces licence with minimum royalty US$200k/quarter | Completed |
| 4 Aug 2025 | M DK step-up to 55% (control) | EUR5.0M; consolidated from 5 Aug 2025 | Completed; integration ongoing |
| Dec 2025 | VIBE retail expansion | VIBE mattresses launched in Walmart stores; plan to build VIBE into a national lifestyle brand | Ongoing |
| 19 Dec 2025 | 2026 Dongguan Lease | One-year connected lease | Completed |
| FY2025 | Cost programme | Office expenses cut ≈HK$6.0M; "various cost control measures" | Ongoing; no quantified target |
| FY2025 | ESG targets | 2030 targets: 5% reduction in emissions, energy and water intensity; ESG scope extended to US and Vietnam factories | Set |
| 1H2026 | Commercial build-out | Heavy investment in sales, marketing, brand awareness and promotion in US and Europe; organisational capability | Ongoing; Q2 2026 expenses below Q1 |
Medium-term targets / guidance
Management has published no quantitative medium-term financial targets (revenue, margin, ROE or leverage) and no formal guidance in the documents reviewed. Guidance is qualitative only (see §22).
Products & Services
Sinomax does not publish a SKU-level catalogue in its regulatory filings, and pricing is not disclosed except where noted. The catalogue below combines filings, trade press and S&P Global-sourced brand lists. Brand ownership status (owned vs licensed) is stated only where verified.
North American market
| Product / brand | Description & capabilities | Target customer | Launch / latest | Pricing | Status / notes |
|---|---|---|---|---|---|
| VIBE® — Original Gel Mattress (12-inch gel memory foam) | Flagship all-foam gel-infused memory-foam mattress shipped compressed (mattress-in-a-box); named "Best Mattress Overall on Amazon" for three consecutive years by Forbes.com | Online consumers (Amazon), mass retail (Walmart from late 2025) | Licensed Nov 2022; brand owned from Jul 2025 | Line designed to retail US$399–699 (queen) per Jan 2023 trade press | Owned (IP bought for US$4.6M, Jul 2025) |
| VIBE 12-inch Quilted Hybrid Mattress | Foam + innerspring hybrid | Online / retail | Pre-2023 assortment, retained | Within US$399–699 queen band | Owned |
| VIBE 8-inch and 10-inch foam; 10-inch and 12-inch hybrid models | Range extensions announced 2023 | Value-to-mid consumers | Planned from Q2 2023 | — | Owned |
| VIBE pillows, toppers, mattress pads, foundation frames | Top-of-bed accessories (e.g., smart-edge pillow; 1.5-inch zoned, 3-inch gel swirl and 4-inch wave toppers announced Mar 2023) | Online / retail | 2023 onwards | — | Owned |
| Mattress-in-a-Box (OEM/private label) | Compressed, roll-packed foam and hybrid mattresses manufactured for retailers and brands; repeatedly cited by management as the key US growth product (FY2022–FY2025 prospects) | US retailers, DTC brands | Ongoing | — | OEM |
| Ecossentials | In-house sustainable sleep line using USDA BioPreferred-certified memory foam and FSC-certified recycled-content packaging | Retail private label & own brand | Showcased Mar 2023 | — | Owned (per trade press) |
| Spa Supreme, ComforZen, Dream Serenity, Zeopedic, Zeosleep, Customizer, Kids Pedic, Cradlez, XCOR, Design, PureLUX, Awaken | Memory-foam pillows, toppers and mattresses under various Sinomax-associated brand names | US retail and online | — | — | — |
| Sharper Image, Homedics (sleep products) | Branded sleep/comfort products under well-known consumer brands | US retail | — | — | — |
| Dormeo Octaspring | Hybrid foam-spring ("Octaspring" foam springs) mattresses and toppers associated with Dormeo North America, in which Sinomax USA invested in Oct 2015 | US consumers | — | — | — |
| Temperature-regulation and bio-based technologies | Carbon-based "adaptive" thermal technology (cools when hot, warms when cold); bio-based antimicrobial and cooling treatments; offered as turnkey solutions for private label | Retail private-label buyers | Introduced spring 2023 | — | Proprietary (per company statements to trade press) |
China market (PRC, Hong Kong, Macau)
| Product / brand | Description | Target customer | Channel | Pricing |
|---|---|---|---|---|
| SINOMAX visco-elastic pillows | Memory-foam contour and standard pillows; the brand's core retail product | Middle-class consumers in HK, Macau and PRC | Own stand-alone shops, department-store concession counters, online platforms | — |
| SINOMAX mattresses and mattress toppers | Memory-foam and hybrid mattresses, toppers | Same | Same | — |
| SINOMAX health and household products | Other comfort products (cushions, lumbar supports etc. — exact range NPD) | Same | Same; also corporate sales | — |
| Tung Ah (東亞) polyurethane foam | Bulk slabstock and specialty polyurethane foam | PRC furniture and upholstery manufacturers | B2B wholesale | Not disclosed; commodity-linked |
Foam sales were HK$1,369.9M in FY2025 (29.2% of Group revenue) and HK$656.0M in 1H2026 (+15.7% YoY).
Europe and other overseas markets
| Product / platform | Description | Notes |
|---|---|---|
| M DK Holdings ApS product range | R&D, design, sourcing, trading, quality assurance and control of sleep products, furniture and home accessories, focused on Denmark, the EU and the US | Consolidated from 5 Aug 2025; contributed HK$603.8M revenue and a HK$11.6M net loss for 5 Aug–31 Dec 2025. The target group holds certain distribution rights granted by affiliates of a licensor, giving rise to a continuing connected transaction under Listing Rule 14A.60 (licensor identity NPD in sources reviewed) |
| Group-manufactured sleep products and foam for European and other customers | Pillows, toppers, mattresses and foam from China/Vietnam | Customer names NPD |
Services
The Group provides no material standalone services. Aggregator profiles mention "provision of treasury management services" as a subsidiary activity; this is intra-group and immaterial to revenue.
Financial Narrative
All figures HK$M, audited, from the FY2022, FY2024 and FY2025 annual results announcements unless noted. FY2022 figures are as originally reported (see §4.4 restatement note).
Income statement
Notes: FY2021 and FY2022 operating profit is derived as PBT plus finance costs (the Group did not present an "operating profit" subtotal in those years). EBITDA = operating profit + depreciation of PP&E, right-of-use assets and investment properties + amortisation; because IFRS 16 right-of-use depreciation is included, EBITDA is post-IFRS 16 and lease-inflated.
Margins and growth
Revenue CAGR: FY2021–FY2025 = 2.5% (distorted by the FY2021 peak and FY2022 collapse); FY2022–FY2025 = 14.2%.
Commentary — income statement. The five-year arc has four distinct phases. FY2021 was a volume peak (revenue +31.8%) on the back of pandemic-era home-goods demand, but the margin structure was poor: gross margin of 16.8% reflected surging chemical feedstock and container-freight costs that the Group could not pass through, leaving a net margin of 0.7%. FY2022 was the trough — revenue fell 26.0%, with China down 33.8% (lockdowns hit both retail and foam demand) and North America down 22.8% (US retailer overstock) — yet gross margin actually rose 3 points to 19.8% as raw-material and freight prices normalised; the loss came from operating deleverage. FY2023–FY2024 was the recovery: gross margin re-based to ~25.5% (lower raw materials, production efficiency), revenue grew at 13–15% a year, operating margin reached 6.0% and net profit doubled to HK$162.6M in FY2024 — the best result of the period.
FY2025: marks an inflection toward "growth with lower quality". Revenue grew 14.8% to a record, but gross margin fell 2.1 points to 23.5% as new 2024 factory leases in Vietnam and the US raised overheads, and US tariffs on exports plus FX losses (net exchange loss HK$22.1M) hit profit. Reported operating profit of HK$167.2M is flattered by an HK$85.0M non-cash remeasurement gain on the previously held 45% M DK stake and depressed by HK$45.1M of impairments on North American PP&E (HK$27.4M) and right-of-use assets (HK$17.7M). Stripping both, underlying operating profit was ~HK$127.3M (2.7% margin), down 48% from FY2024. Selling expenses grew faster than revenue (+19.3%), driven by marketing (+HK$57.9M) and transport (+HK$19.3M); admin rose 16.2% on headcount. Tax losses not recognised jumped to HK$45.5M of tax effect, signalling loss-making subsidiaries (most likely the US and the newly consolidated M DK).
1H2026 interim snapshot
The 1H2026 pattern intensifies FY2025's: gross margin recovered 3.0 points on mix (more higher-margin segments), but selling costs jumped 64.3% (channel fees +HK$63.0M, marketing +HK$44.9M, transport +HK$40.1M) and admin 55% (staff +HK$47.9M). Management notes Q2 expenses fell versus Q1, and blames March–April 2026 Middle East-related raw-material and logistics cost spikes it could not fully pass on (profit warning, 6 Aug 2026).
Balance sheet
Notes: No goodwill line was presented in FY2021/FY2022 balance sheets (shown as 0). The origin of the HK$5.3M goodwill first appearing in FY2023 is not explained in the documents reviewed. All bank borrowings are classified current/repayable on demand in every year. At 30 Jun 2026: cash HK$262.9M; bank borrowings HK$735.5M (trade financing 454.6; revolving 156.0; term 125.0); leases HK$266.8M; goodwill HK$177.5M; owners' equity HK$1,062.8M.
Commentary — balance sheet. Two features dominate. First, all bank debt is short-term (trade finance, revolvers and on-demand term loans), refinanced continuously against facilities of HK$1,658.1M (HK$795.2M utilised at 30 Jun 2026). This has worked through the cycle, but covenant breaches in 2020 and 2022 (the latter on HK$35.9M, waived) show the structure's fragility. Second, the balance sheet is being re-levered to fund growth: net bank debt (excluding leases) more than doubled from HK$138.7M (FY2024) to HK$327.8M (FY2025) and rose further to ~HK$472.6M at 30 Jun 2026, while the company's own debt-to-equity (net debt/equity) ratio went from 13.9% to 30.4% to 43.0%. The M DK step-acquisition added HK$168.8M of goodwill against net identifiable assets of only HK$31.8M — i.e., ~91% of the consideration is goodwill attached to a business that lost money after consolidation. Working capital also absorbed cash: receivables over 180 days rose from HK$38.5M (Dec 2025) to HK$69.2M (Jun 2026) and the credit-loss allowance from HK$25.0M to HK$35.9M.
Cash flow
Notes: Lease principal repayments (financing cash flows) were not available in the announcements reviewed, so "free cash flow" here is before lease payments; given right-of-use depreciation of HK$84–106M a year, lease-adjusted FCF would be materially lower. Dividends to owners derived: FY2024 = FY2023 final (HK1.3¢ × 1,750M = HK$22.75M) + FY2024 interim (HK$17.5M); FY2025 = FY2024 final (HK$22.75M) + FY2025 interim (HK$8.75M). No buybacks in FY2022–FY2025 (confirmed in each results announcement); FY2021 assumed nil (not separately verified). 1H2026 operating cash flow: HK$8.3M (1H2025: HK$33.8M); 1H2026 capex HK$36.9M.
Commentary — cash flow. FY2023's HK$420.3M operating cash flow was a working-capital release year (inventory down, payables up), not a structural level. Since then operating cash flow has fallen every period while capex has risen, and 1H2026 operating cash flow of just HK$8.3M against HK$36.9M capex means the Group funded growth, dividends and lease payments with borrowings. Dividend cuts (FY2025 total DPS down 57%; no 1H2026 interim) are consistent with conserving cash.
Ratios
ROIC uses the effective tax rate (bounded 0–50%). Year-end balances for DIO/DSO/DPO; FY2025 balances include M DK consolidated for only five months of income, which inflates DSO/DIO.
Ratio commentary. FY2024 was the high-water mark on every return metric (ROE 14.5%, ROIC 13.5%, coverage 4.9x). FY2025 roughly halved returns despite record revenue, and FY2025 interest coverage of 2.8x falls to ~2.1x on an underlying basis (excluding the remeasurement gain and impairments). The company-reported gearing ratio of 64.5% (FY2025) and 66.9% (Jun 2026) is the highest of the five-year window.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | What it contains | Products / services |
|---|---|---|
China market | Manufacture and sale to customers in the PRC, Hong Kong and Macau | Health and household products (SINOMAX retail, concession counters, e-commerce, corporate sales) and polyurethane foam (Tung Ah) to furniture makers |
North American market | Manufacture and sale to customers in the US, Canada and other North American countries | Health and household products (mattresses incl. mattress-in-a-box, toppers, pillows; OEM/private label; VIBE brand; e-commerce) |
Europe and other overseas markets | All other customers | Health and household products and foam; since Aug 2025 includes consolidated M DK Holdings (Denmark/EU trading) |
Segment revenue (HKD Mn)
| Segment revenue (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
China market (HKD Mn) | 2,222.9 | 1,470.7 | 1,589.6 | 1,748.8 | 1,857.7 |
North American market (HKD Mn) | 1,573.4 | 1,214.2 | 1,384.7 | 1,624.6 | 1,773.6 |
Europe and other overseas markets (HKD Mn) | 463.6 | 467.0 | 634.6 | 717.7 | 1,065.4 |
Total (HKD Mn) | 4,259.9 | 3,152.0 | 3,608.9 | 4,091.1 | 4,696.7 |
Segment YoY growth (%)
| Segment YoY growth (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
China market YoY (%) | 0 | -33.8 | 8.1 | 10.0 | 6.2 |
North American market YoY (%) | 0 | -22.8 | 14.0 | 17.3 | 9.2 |
Europe and other overseas YoY (%) | 0 | 0.7 | 35.9 | 13.1 | 48.4 |
Total YoY (%) | 0 | -26.0 | 14.5 | 13.4 | 14.8 |
Segment share of revenue (%)
| Segment share of revenue (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
China market (%) | 52.2 | 46.7 | 44.0 | 42.7 | 39.6 |
North American market (%) | 36.9 | 38.5 | 38.4 | 39.7 | 37.8 |
Europe and other overseas (%) | 10.9 | 14.8 | 17.6 | 17.5 | 22.7 |
Revenue by Segment
| Segment (HKD Mn) | 1H2025 | 1H2026 | Change (%) |
|---|---|---|---|
China market | 792.5 | 962.8 | 21.5 |
North American market | 692.0 | 1,138.9 | 64.6 |
Europe and other overseas | 407.6 | 474.6 | 16.5 |
Total | 1,892.1 | 2,576.3 | 36.2 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansGroup Entities
| Entity | Jurisdiction | Role |
|---|---|---|
Sinomax Group Limited | Cayman Islands | Listed holding company |
Sinomax Enterprises Limited | BVI | Controlling shareholder (parent) |
Treasure Range Holdings Limited | — | Wholly owned; holds the 55% stake in M DK Holdings ApS |
M DK Holdings ApS ("MDKH") and subsidiaries | Denmark (operations in Denmark, EU and US) | 55% subsidiary since 4 Aug 2025; 45% held by M Logistical |
Sinomax USA, Inc. | United States (Houston, TX HQ) | US manufacturing, sales; owner of VIBE IP |
Sinomax (Vietnam) Polyurethane Technology ("Sinomax Vietnam") | Vietnam | Manufacture and sale of polyurethane foam |
Sinomax Vietnam Household Products ("Sinomax Vietnam HP") | Vietnam | Manufacture and sale of health and household products |
Sinomax (Zhejiang) Polyurethane Technology Limited | PRC | Foam; former owner of Chengdu Xingang stake |
Sinomax (Zhejiang) Polyurethane Household Products Ltd. | PRC | Household products |
Sinomax Kuka Zhejiang Foam Co. | PRC (Haining) | Foam; lessee under Haining lease |
Sinomax Health & Household Products Ltd. | — | Health & household products |
Sinomax Macao Commercial Offshore Ltd. | Macau | Trading |
Sinomax International Trading Ltd. / Sinomax International Investment Ltd. | — | Trading / holding |
“—” = not publicly disclosed.
Income statement (HKD Mn)
| Income statement (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 4,259.9 | 3,152.0 | 3,608.9 | 4,091.1 | 4,696.7 |
Cost of sales (HKD Mn) | 3,542.9 | 2,529.2 | 2,689.2 | 3,044.2 | 3,594.4 |
Gross profit (HKD Mn) | 717.0 | 622.7 | 919.7 | 1,047.0 | 1,102.3 |
Selling and distribution expenses (HKD Mn) | 420.2 | 424.5 | 458.4 | 494.3 | 589.7 |
Administrative expenses (HKD Mn) | 199.2 | 188.7 | 250.2 | 267.4 | 310.8 |
Research and development costs (HKD Mn) | 67.4 | 74.4 | 80.2 | 88.0 | 89.7 |
Other income (HKD Mn) | 63.1 | 54.1 | 27.9 | 54.9 | 45.7 |
Other gains/(losses), net (HKD Mn) | -11.7 | 25.5 | 14.9 | -11.9 | 16.0 |
Operating profit (HKD Mn) | 76.8 | -3.2 | 172.4 | 244.6 | 167.2 |
Depreciation and amortisation incl. right-of-use (HKD Mn) | 160.2 | 168.5 | 150.2 | 159.7 | 192.9 |
EBITDA, derived (HKD Mn) | 237.0 | 165.3 | 322.6 | 404.2 | 360.0 |
Finance costs (HKD Mn) | 38.9 | 46.0 | 49.8 | 50.1 | 59.1 |
Share of associate (HKD Mn) | 0 | 0 | 0 | 5.0 | -0.2 |
Profit/(loss) before tax (HKD Mn) | 37.9 | -49.2 | 122.6 | 199.5 | 107.9 |
Income tax expense/(credit) (HKD Mn) | 6.4 | -12.0 | 42.1 | 36.8 | 23.0 |
Profit/(loss) for the year (HKD Mn) | 31.4 | -37.2 | 80.5 | 162.6 | 84.8 |
Attributable to owners (HKD Mn) | 15.3 | -36.0 | 62.6 | 138.1 | 60.3 |
Attributable to non-controlling interests (HKD Mn) | 16.1 | -1.2 | 17.9 | 24.6 | 24.5 |
Basic EPS (HK cents) | 0.87 | -2.06 | 3.58 | 7.89 | 3.45 |
Diluted EPS (HK cents) | 0.87 | -2.06 | 3.58 | 7.89 | 3.45 |
Final DPS (HK cents) | 0.4 | 0 | 1.3 | 1.3 | 0.5 |
Margins and growth (%)
| Margins and growth (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue growth YoY (%) | 31.8 | -26.0 | 14.5 | 13.4 | 14.8 |
Gross margin (%) | 16.8 | 19.8 | 25.5 | 25.6 | 23.5 |
Operating margin (%) | 1.8 | -0.1 | 4.8 | 6.0 | 3.6 |
EBITDA margin (%) | 5.6 | 5.2 | 8.9 | 9.9 | 7.7 |
Net margin (%) | 0.7 | -1.2 | 2.2 | 4.0 | 1.8 |
R&D as % of revenue (%) | 1.6 | 2.4 | 2.2 | 2.2 | 1.9 |
S&D as % of revenue (%) | 9.9 | 13.5 | 12.7 | 12.1 | 12.6 |
Admin as % of revenue (%) | 4.7 | 6.0 | 6.9 | 6.5 | 6.6 |
1H income statement (HKD Mn)
| 1H income statement (HKD Mn) | 1H2025 | 1H2026 |
|---|---|---|
Revenue | 1,892.1 | 2,576.3 |
Gross profit | 442.4 | 680.7 |
Gross margin (%) | 23.4 | 26.4 |
Selling and distribution | 235.1 | 386.2 |
Administrative | 119.2 | 184.9 |
R&D | 39.2 | 47.5 |
Operating profit | 53.3 | 51.6 |
Finance costs | 24.7 | 29.1 |
Profit for the period | 30.4 | 20.0 |
Attributable to owners | 26.9 | 11.8 |
Basic EPS (HK cents) | 1.54 | 0.67 |
Balance Sheet
| Balance sheet (HKD Mn, at 31 Dec) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 2,828.9 | 2,237.9 | 2,406.1 | 2,557.0 | 3,244.0 |
Cash and cash equivalents (HKD Mn) | 228.5 | 169.0 | 309.9 | 262.4 | 367.8 |
Unsecured bank borrowings — current (HKD Mn) | 588.3 | 522.3 | 441.9 | 401.1 | 695.6 |
Bank borrowings — non-current (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Lease liabilities — current (HKD Mn) | 84.1 | 63.5 | 72.6 | 91.9 | 124.0 |
Lease liabilities — non-current (HKD Mn) | 272.5 | 236.2 | 208.1 | 250.8 | 240.4 |
Total debt incl. leases (HKD Mn) | 944.9 | 822.0 | 722.6 | 743.8 | 1,060.1 |
Net debt incl. leases (HKD Mn) | 716.3 | 653.0 | 412.7 | 481.4 | 692.3 |
Net bank debt excl. leases (HKD Mn) | 359.7 | 353.3 | 132.0 | 138.7 | 327.8 |
Total equity (HKD Mn) | 1,006.6 | 886.9 | 918.5 | 999.8 | 1,079.2 |
Equity attributable to owners (HKD Mn) | 992.8 | 895.2 | 925.8 | 973.7 | 1,032.0 |
Non-controlling interests (HKD Mn) | 13.8 | -8.3 | -7.3 | 26.1 | 47.3 |
Goodwill (HKD Mn) | 0 | 0 | 5.3 | 5.2 | 177.3 |
Intangible assets (HKD Mn) | 13.0 | 11.2 | 9.4 | 7.6 | 49.8 |
Inventories (HKD Mn) | 703.3 | 555.3 | 508.7 | 476.5 | 660.1 |
Trade receivables, net (HKD Mn) | 658.7 | 435.7 | 542.9 | 626.0 | 837.3 |
Trade payables (HKD Mn) | 598.7 | 310.2 | 452.7 | 487.0 | 705.1 |
Net current assets / working capital (HKD Mn) | 377.7 | 277.0 | 339.4 | 370.2 | 290.6 |
Cash flow (HKD Mn)
| Cash flow (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Net cash from operating activities (HKD Mn) | 156.8 | 191.0 | 420.3 | 249.9 | 207.0 |
Capital expenditure (HKD Mn) | 48.6 | 51.0 | 62.2 | 65.8 | 92.8 |
Free cash flow before lease payments, derived (HKD Mn) | 108.2 | 140.0 | 358.1 | 184.1 | 114.2 |
Dividends paid to owners, derived (HKD Mn) | NPD | NPD | NPD | 40.3 | 31.5 |
Dividends paid to NCI (HKD Mn) | 4.9 | 14.0 | 15.2 | 2.7 | 21.8 |
Share buybacks (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%) and Financial Ratios (x)
| Ratios | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE on average owners' equity (%) | 1.5 | -3.8 | 6.9 | 14.5 | 6.0 |
ROA on average total assets (%) | 1.1 | -1.5 | 3.5 | 6.6 | 2.9 |
ROIC, after-tax operating profit / (equity + net debt) (%) | 3.7 | -0.2 | 8.5 | 13.5 | 7.4 |
Current ratio (x) | 1.25 | 1.25 | 1.27 | 1.29 | 1.15 |
Quick ratio, company-reported (%) | 78.7 | 74.6 | 86.6 | 91.8 | 80.7 |
Gearing ratio, company-reported interest-bearing debt / equity (%) | 58.4 | 58.9 | 48.1 | 40.1 | 64.5 |
Debt-to-equity, company-reported net debt / equity (%) | 35.7 | 39.8 | 14.4 | 13.9 | 30.4 |
Total debt incl. leases / equity (x) | 0.94 | 0.93 | 0.79 | 0.74 | 0.98 |
Net debt incl. leases / EBITDA (x) | 3.02 | 3.95 | 1.28 | 1.19 | 1.92 |
Interest coverage, operating profit / finance costs (x) | 1.97 | -0.07 | 3.46 | 4.88 | 2.83 |
Asset turnover (x) | 1.51 | 1.24 | 1.55 | 1.65 | 1.62 |
Days inventory outstanding (days) | 72.5 | 80.1 | 69.1 | 57.1 | 67.0 |
Days sales outstanding (days) | 56.4 | 50.5 | 54.9 | 55.9 | 65.1 |
Days payables outstanding (days) | 61.7 | 44.8 | 61.5 | 58.4 | 71.6 |
Cash conversion cycle (days) | 67.2 | 85.8 | 62.5 | 54.6 | 60.5 |
Revenue by country/region (HKD Mn)
| Revenue by country/region (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
PRC (HKD Mn) | 1,913.1 | 1,222.1 | 1,295.2 | 1,481.6 | 1,521.6 |
Hong Kong, Macau and others (HKD Mn) | 309.8 | 248.6 | 294.5 | 267.2 | 336.1 |
United States (HKD Mn) | 1,443.0 | 1,128.8 | 1,280.8 | 1,379.4 | 1,550.7 |
Other North America (HKD Mn) | 130.5 | 85.4 | 103.9 | 245.2 | 222.9 |
Europe and other overseas (HKD Mn) | 463.6 | 467.0 | 634.6 | 717.7 | 1,065.4 |
Total (HKD Mn) | 4,259.9 | 3,152.0 | 3,608.9 | 4,091.1 | 4,696.7 |
Country/region YoY growth (%)
| Country/region YoY growth (%) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
PRC (%) | 6.0 | 14.4 | 2.7 |
Hong Kong, Macau and others (%) | 18.4 | -9.3 | 25.8 |
United States (%) | 13.5 | 7.7 | 12.4 |
Other North America (%) | 21.6 | 136.1 | -9.1 |
Europe and other overseas (%) | 35.9 | 13.1 | 48.4 |
1H revenue by country (HKD Mn)
| 1H revenue by country (HKD Mn) | 1H2025 | 1H2026 | Change (%) |
|---|---|---|---|
PRC | 665.9 | 800.8 | 20.3 |
Hong Kong, Macau and others | 126.6 | 162.0 | 27.9 |
United States | 578.4 | 1,024.0 | 77.0 |
Other North America | 113.6 | 114.9 | 1.1 |
Europe and other overseas | 407.6 | 474.6 | 16.5 |
Non-current assets by location (HKD Mn)
| Non-current assets by location (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
United States (HKD Mn) | 493.3 | 461.9 | 405.7 | 386.7 | 438.0 |
PRC (HKD Mn) | 324.6 | 268.7 | 283.9 | 253.6 | 247.8 |
Hong Kong (HKD Mn) | 12.3 | 16.9 | 24.7 | 24.6 | 23.9 |
Vietnam (HKD Mn) | 45.6 | 27.7 | 27.5 | 91.0 | 86.7 |
Europe (HKD Mn) | 0 | 0 | 0 | 54.7 | 162.7 |
Year-end share price (HKD)
| Year-end share price (HKD) | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
Closing price at 31 Dec (HKD) | 0.235 | 0.069 | 0.070 | 0.250 |
Performance Details
| Performance (approximate, to 17 Sep 2026) | Value |
|---|---|
~1-year (vs ~HK$0.22, Sep–Oct 2025) | ≈ −45% |
~3-year (vs HK$0.070 at end-2023) | ≈ +71% |
~5-year (vs HK$0.235 at end-2021) | ≈ −49% |
Annualised return since 2014 listing (Lixinger, mid-2026) | −12.06% |
Valuation Snapshot
| Metric | Value | Basis |
|---|---|---|
Market capitalisation | HK$210.0M | 1,750.0M shares × HK$0.12 |
Enterprise value | ≈HK$987M | Market cap + bank borrowings 735.5 + lease liabilities 266.8 − cash 262.9 + NCI 37.4 (30 Jun 2026) |
P/E (TTM attributable earnings HK$45.2M) | ≈4.6x | H2 2025 HK$33.4M + 1H2026 HK$11.8M; Lixinger 4.65x |
P/B | ≈0.20x | Owners' equity HK$1,062.8M (Jun 2026); 10jqka 0.21x |
EV/Sales (TTM revenue HK$5,380.9M) | ≈0.18x | H2 2025 HK$2,804.6M + 1H2026 HK$2,576.3M |
EV/EBITDA (TTM EBITDA ≈HK$372.6M, post-IFRS 16) | ≈2.6x | H2 2025 HK$216.0M + 1H2026 HK$156.6M; includes FY2025 one-offs |
Dividend per share (HK cents)
| Dividend per share (HK cents) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Final DPS (HK cents) | 0.4 | 0 | 1.3 | 1.3 | 0.5 |
Capital Instruments
| Instrument | Amount (HKD Mn) | Maturity | Pricing |
|---|---|---|---|
Trade financing | 454.6 | Within 1 year | HIBOR / SOFR / LPR + margin |
Revolving borrowings | 156.0 | Within 1 year / on demand | Variable |
Term borrowings | 125.0 | Within 1 year / on demand | Variable or fixed (some PRC loans 2.00–2.42%) |
Total bank borrowings | 735.5 | All current | Effective rates 2.00–6.69% |
Lease liabilities — current | 97.9 | Within 1 year | — |
Lease liabilities — non-current | 168.8 | Beyond 1 year | — |
Banking facilities available | 1,658.1 | — | HK$795.2M utilised (incl. bill payables); no assets pledged |
Analyst Conclusions
Management guidance
Qualitative only. For 2H2026, management intends to leverage the enlarged MDKH platform to deepen US and European penetration, strengthen sales and marketing, broaden the customer base, streamline operations and improve cost efficiency, while monitoring trade policy and raw-material costs; the Board remains "cautiously optimistic". No numerical revenue, margin or earnings guidance has been given.
Consensus expectations
No sell-side consensus is publicly available (see §21.3). Mechanically, a full year of M DK consolidation (versus five months in FY2025) and 1H2026's +36% growth point to FY2026 revenue well above FY2025's HK$4.7bn, but earnings direction depends on 2H cost discipline.
Bull case
-
Scale is arriving faster than expected: 1H2026 revenue +36.2% and gross profit +53.9%; full-year MDKH consolidation and VIBE retail rollout could take FY2026 revenue towards a new record with a structurally higher gross margin (26.4% in 1H2026 vs 23.5% FY2025).
-
Cost normalisation creates operating leverage: selling expenses at 15.0% of 1H2026 revenue versus 12.1% in FY2024; reversion toward ~12–13% on a >HK$5bn revenue base would add tens of millions in operating profit, and management notes Q2 costs already fell versus Q1.
-
Extreme valuation cushion: at ~0.2x book, ~4.6x trailing P/E and ~2.6x EV/EBITDA, the market prices in permanent impairment; any stabilisation of earnings could re-rate the shares meaningfully, and dividends have been maintained at a ~30% payout through FY2025.
Bear case
-
Growth is being bought, not earned: attributable profit fell 56% in both FY2025 and 1H2026 despite rising sales; underlying FY2025 operating margin was ~2.7%, and three consecutive profit warnings (Aug 2025, Feb 2026, Aug 2026) show poor earnings visibility.
-
Balance-sheet and cash-flow strain: gearing 66.9%, all bank debt short-term, 1H2026 operating cash flow of only HK$8.3M, and the interim dividend suspended — a further profit shock could revive the covenant issues of 2020/2022.
-
Asset-quality risks: HK$177.5M of goodwill (mostly MDKH, loss-making post-acquisition), HK$45.1M of US impairments already booked, and rising long-dated receivables (HK$69.2M aged 181–365 days) point to possible further write-downs.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| Ongoing | US tariff policy changes affecting China/Vietnam-made bedding; anti-dumping reviews |
| Ongoing | Polyol/isocyanate prices and freight after the Mar–Apr 2026 Middle East disruption |
| Feb 2027 (expected) | Possible FY2026 profit alert (pattern of February/August warnings) |
| Mar 2027 (expected) | FY2026 annual results — full-year MDKH contribution, goodwill impairment test, US asset utilisation, final dividend decision |
| 2026–2027 | Renewal of PRC HNTE 15% tax status (expires 2026) |
| 2026–2027 | Renewal of 2024–2026 Haining lease; 2027 Dongguan lease (connected transactions) |
| Ongoing | VIBE retail distribution beyond Amazon/Walmart |
| Ongoing | Receivable ageing, credit-loss allowances, operating cash flow and gearing trajectory |
| 2,027 | HKFRS 18 adoption with restated 2026 comparatives |
Concluding analyst verdict
Sinomax has executed a credible strategic pivot since the FY2022 trough: it rebuilt gross margins to the mid-20s, diversified away from a China-centric foam business, built a three-country production network suited to an era of tariffs and anti-dumping duties, bought an Amazon-proven mattress brand cheaply, and acquired control of a European distribution platform. Revenue is at record levels and accelerating, with 1H2026 up 36% and the United States up 77%.
The problem is that almost none of this growth has reached shareholders. Attributable profit has fallen by more than half in each of the last three reported periods, and FY2025's headline profit was flattered by an HK$85M non-cash remeasurement gain. Selling, channel and staff costs are rising faster than gross profit; operating cash flow has collapsed to near zero in 1H2026; gearing is at a five-year high with every dollar of bank debt short-term; and the balance sheet now carries HK$177M of goodwill tied to a loss-making acquisition. The Group's history of covenant breaches in 2020 and 2022 means these trends deserve close attention.
The market has priced this scepticism aggressively: a ~HK$210M market capitalisation, ~0.2x book and ~4.6x trailing earnings imply that investors either expect write-downs or discount the controlling shareholder's ~73% stake and related-party lease arrangements. For a value investor the asymmetry is real — modest cost normalisation on a HK$5bn+ revenue base would transform earnings — but it is contingent on management demonstrating in 2H2026 that the commercial build-out is ending and that MDKH can break even.
Verdict: a deep-value, high-execution-risk special situation rather than a quality compounder. Evidence to watch before taking a constructive view: FY2026 operating cash flow turning positive, selling-expense ratio falling back toward 12–13%, no goodwill impairment on MDKH, and gearing stabilising. Absent those, the low multiple is more likely a value trap than an opportunity.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Director since (per aggregator) | Year of birth / age | Background (verified items only) |
|---|---|---|---|---|
Mr. LAM Chi Fan ("Frankie Lam") | Non-executive Director, Chairman of the Board; Chairman of the Nomination Committee | 2012 | Born 1959 | Founder-era Chairman; re-designated from executive to non-executive Director (date per 2024 Annual Report, between Mar 2023 and Feb 2025) |
Mr. CHEUNG Tung | Executive Director, President | 2012 (President since 2003 per Zonebourse) | Born 1976 | Director of multiple PRC and offshore subsidiaries (Sinomax Kuka Zhejiang Foam, Sinomax (Zhejiang) Polyurethane Household Products, Sinomax Macao Commercial Offshore etc.); former director of Sinomax USA |
Mr. CHEN Feng | Executive Director | 2012 | Born 1964 | Detailed bio NPD in sources reviewed |
Mr. LAM Kam Cheung ("Kelvin Lam") | Executive Director, Chief Financial Officer and Company Secretary; authorised representative | 2012 | Born 1968 | Joined Dormeo NA board in 2015 on Sinomax's investment |
Ms. LAM Fei Man | Executive Director | 2012 | Born 1975 | — |
Mr. WONG Chi Keung | Independent Non-executive Director; Chairman of the Audit Committee and of a second board committee | 2014 | Age 54 (Investing.com) | INED since listing |
Mr. ZHANG Hwo Jie | Independent Non-executive Director | 2014 | Age 60 (Investing.com) | — |
Dr. CHEUNG Wah Keung | Independent Non-executive Director | 2023 | Age 62 (Investing.com) | Appointed in the June 2023 board refresh |
Directors' Remuneration
| Director | Total pay (HKD Mn, FY2023 per aggregator) | Salary / bonus / equity split |
|---|---|---|
Chen Feng | 2.29 | NPD |
Cheung Tung | 2.11 | NPD |
Lam Chi Fan | 2.04 | NPD |
Lam Kam Cheung | 1.92 | NPD |
Lam Fei Man | 1.25 | NPD |
Board & Management Changes
| Date | Change |
|---|---|
12 Jun 2023 | INED resignation (Prof. Lam Sing Kwong Simon per committee-history inference; name not explicitly confirmed in retrieved text) and committee changes |
16 Jun 2023 | Committee re-composition |
28 Jun 2023 | Further director appointments/re-designations; Dr Cheung Wah Keung joins as INED |
Mar 2023–Feb 2025 | Lam Chi Fan re-designated from executive Director to non-executive Director (Chairman) |
16 May 2025 | Change affecting Ms Lam Fei Man (per 2025 Interim Report) |
Major Shareholders
| Holder | Shares | % | As at |
|---|---|---|---|
Sinomax Enterprises Limited (BVI, controlling shareholder) | 1,275,906,000 | 72.91 | Nov 2019 (latest verified) |
Public float (implied) | ~474,096,000 | ~27.09 | Nov 2019 |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Type | Relative positioning |
|---|---|---|---|
North America — branded & OEM bedding | Somnigroup International (formerly Tempur Sealy; NYSE: SGI) | Global leader; owns Tempur-Pedic memory foam brand | Category creator in visco-elastic; vastly larger scale and brand power; competitor and potential customer |
North America | Serta Simmons Bedding (private) | Major US mattress maker | Historically a Sinomax customer; also a competitor in branded mattresses |
North America | Sleep Number (NASDAQ: SNBR) | Vertically integrated smart-bed retailer | Different model (own stores); competes for premium sleep spend |
North America — bed-in-a-box | Zinus (Hyundai Livart group, Korea) | Large-scale Asian-manufactured mattress-in-a-box | Direct rival on Amazon/Walmart value mattresses — closest analogue to VIBE |
North America — bed-in-a-box | Casper, Nectar/Resident (private) | DTC brands | Compete for online share; also outsource manufacturing |
North America — foam OEM | Healthcare Co. Ltd. / MLILY (Shanghai-listed) | Chinese memory-foam OEM/ODM with US factories | Most direct global peer: same product set, same customer types, same tariff exposure |
North America — foam | Keeson Technology (Shanghai-listed) | Smart beds/adjustable bases, mattress OEM | Adjacent OEM competitor |
China — branded retail | De Rucci (Shenzhen-listed), Xilinmen (Shanghai-listed) | Chinese mattress brands | Much larger domestic brands; compete for SINOMAX retail customers |
China — foam | Regional PU foam converters (fragmented; names NPD) | Commodity foam | Price-based competition for furniture-maker volume |
Hong Kong home furnishings | International Housewares Retail (1373.HK), Royale Home (1198.HK), Hing Lee (HK) (0396.HK), Morris Home (1575.HK), Huisen Household (2127.HK) | HK-listed home goods/furniture peers | Comparable small-cap valuation universe |
Europe | Emma (Germany), Dormeo/Studio Moderna, regional sourcing houses | Bed-in-a-box and trading | Compete with the M DK platform |
Peer Comparison FY2025
| Company | Ticker | Price (HKD) | Market cap (HKD Mn) | P/E (x) | 1-year price change (%) |
|---|---|---|---|---|---|
Sinomax Group | 1418.HK | 0.23 | 390.25 | 3.79 | 6.67 |
International Housewares Retail | 1373.HK | 0.77 | 557.14 | 11.76 | -22.00 |
Royale Home Holdings | 1198.HK | 0.15 | 384.59 | NPD (loss) | -45.19 |
Hing Lee (HK) Holdings | 0396.HK | 0.12 | 96.16 | 5.69 | 25.88 |
Morris Home Holdings | 1575.HK | 0.05 | 183.78 | NPD | -28.57 |
Huisen Household International | 2127.HK | 0.02 | 76.58 | NPD | -56.52 |
Sinomax internal benchmark | FY2023 | FY2024 | FY2025 | — | — |
Revenue growth (%) | 14.5 | 13.4 | 14.8 | — | — |
Gross margin (%) | 25.5 | 25.6 | 23.5 | — | — |
Operating margin (%) | 4.8 | 6.0 | 3.6 | — | — |
R&D intensity (%) | 2.2 | 2.2 | 1.9 | — | — |



